Kinetic Analysis of Leucine‐Enkephalin Cellular Uptake at the Luminal Side of the Blood‐Brain Barrier of an In Situ Perfused Guinea‐Pig Brain
- 1 November 1989
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 53 (5) , 1333-1340
- https://doi.org/10.1111/j.1471-4159.1989.tb08522.x
Abstract
The uptake of enkephalin-(5-L-leucine) (Leu-en-kephalin) at the luminal side of the blood-brain barrier was measured by means of an in situ vascular brain perfusion technique in the anaesthetized guinea pig. This method allows measurements of cerebrovascular peptide uptake over periods of up to 20 min, and excludes the solute under study from the general circulation and systemic metabolic influences. A capillary unidirectional transfer constant, Kin, for [tyrosyl-3,5-3H]Leu-enkephalin was estimated graphically from the multiple-time brain uptake data in the presence of different concentrations of unlabelled peptide, and dose-dependent self-inhibition was demonstrated. Analysis of unidirectional influx of blood-borne Leu-en kephalin into the brain revealed Michaelis-Menten saturation kinetics in the parietal cortex, caudate nucleus, and hippocampus, with Vmax between 0.14 and 0.16 nmol min−1 g−1 and Km ranging from 34 to 41 μM, for the saturable component, whereas the estimated diffusion constant, Kd, was not significantly different from zero. Entry of [3H]Leu-enkephalin was not inhibited in the presence of either a 5 mM concentration of unlabelled L-tyrosine, tyro-sylglycine, and tyrosylglycylglycine, or aminopeptidase inhibitor, bestatin (0.5 mM), suggesting that the saturable mechanism of the tracer at the luminal side of the blood-brain barrier does not involve uptake of the peptide's N-terminal amino acid and/or its tyrosine-containing fragments. The specific δ-opioid antagonist, allyl2-Tyr-AIB-Phe-OH, and μ-opioid receptor agonist, Tyr-D-Ala-Gly-Me-Phe-NH(CH2)20H, at concentrations in the perfusate above the Km value for the saturable transport of Leu-enkephalin, did not affect significantly uptake of [3H]Leu-enkephalin. The present study provides, for the first time, a characterization of the kinetic parameters of the unidirectional uptake of a peptide from the luminal side of the blood-brain barrierKeywords
This publication has 56 references indexed in Scilit:
- Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrierPeptides, 1988
- Recent Advances in Blood-Brain Barrier TransportAnnual Review of Pharmacology and Toxicology, 1988
- Saturable transport of peptides across the blood-brain barrierLife Sciences, 1987
- Mechanisms of Neuropeptide Interaction with the Blood‐Brain BarrieraAnnals of the New York Academy of Sciences, 1986
- A comparison of methods for estimating the kinetic parameters of two simple types of transport processBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Modulation of substrate transport to the brainActa Neurologica Scandinavica, 1983
- Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examinationBrain Research Reviews, 1982
- Kinetics of Neutral Amino Acid Transport Through the Blood‐Brain Barrier of the Newborn RabbitJournal of Neurochemistry, 1982
- EnkephalinasesProceedings of the Royal Society of London. B. Biological Sciences, 1980
- Mlab — A mathematical modeling toolComputer Programs in Biomedicine, 1979